Metastatic ovarian, prostate and breast cancers are notoriously difficult to treat and often deadly. Now, researchers have revealed a new role for the CDK12 protein.
New role for a driver of metastatic cancers
Metastatic ovarian, prostate and breast cancers are notoriously difficult to treat and often deadly. Now, researchers have revealed a new role for the CDK12 protein.
